Literature DB >> 10542032

Sequence and initial characterization of the U(L)10 (glycoprotein M) and U(L)11 homologous genes of serotype 1 Marek's Disease Virus.

N Osterrieder1.   

Abstract

The nucleotide sequence of the U(L)10 (glycoprotein M) and the U(L)11 homologs of Marek's Disease Virus 1 strain GA was determined. The U(L)10 open reading frame encodes a type III membrane protein of 424 amino acids that contains eight hydrophobic domains and two consensus N-linked glycosylation sites. The U(L)11 homologous gene encodes an 84 amino acid polypeptide, and contains a highly conserved myristylation site at its aminoterminus. By analysis of infected-cell RNA with strand-specific RNA probes, transcription of both U(L)10 and U(L)11 in infected cells was demonstrated. Coupled in vitro transcription-translation confirmed that the U(L)10 product is a 47 kD N-glycosylated viral protein that aggregated upon boiling, whereas the U(L)11 protein exhibited a size of 12 kD after in vitro translation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10542032     DOI: 10.1007/s007050050710

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  17 in total

1.  Identification of 10 cowpox virus proteins that are necessary for induction of hemorrhagic lesions (red pocks) on chorioallantoic membranes.

Authors:  Zhiyong Xu; Dimitrios Zikos; Aistė Tamošiūnaitė; Robert Klopfleisch; Nikolaus Osterrieder; B Karsten Tischer
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

2.  Role of the short telomeric repeat region in Marek's disease virus replication, genomic integration, and lymphomagenesis.

Authors:  Annachiara Greco; Nadine Fester; Annemarie T Engel; Benedikt B Kaufer
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

3.  Glycoproteins E and I of Marek's disease virus serotype 1 are essential for virus growth in cultured cells.

Authors:  D Schumacher; B K Tischer; S M Reddy; N Osterrieder
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

4.  Reconstitution of Marek's disease virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial chromosome and characterization of a glycoprotein B-negative MDV-1 mutant.

Authors:  D Schumacher; B K Tischer; W Fuchs; N Osterrieder
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

5.  Herpesvirus telomerase RNA(vTR)-dependent lymphoma formation does not require interaction of vTR with telomerase reverse transcriptase (TERT).

Authors:  Benedikt B Kaufer; Sascha Trapp; Keith W Jarosinski; Nikolaus Osterrieder
Journal:  PLoS Pathog       Date:  2010-08-26       Impact factor: 6.823

6.  Deletion in open reading frame 49 of varicella-zoster virus reduces virus growth in human malignant melanoma cells but not in human embryonic fibroblasts.

Authors:  Tomohiko Sadaoka; Hironori Yoshii; Takayoshi Imazawa; Koichi Yamanishi; Yasuko Mori
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

7.  The pseudorabies virus UL11 protein is a virion component involved in secondary envelopment in the cytoplasm.

Authors:  Martina Kopp; Harald Granzow; Walter Fuchs; Barbara G Klupp; Egbert Mundt; Axel Karger; Thomas C Mettenleiter
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

8.  Enzymatically inactive U(S)3 protein kinase of Marek's disease virus (MDV) is capable of depolymerizing F-actin but results in accumulation of virions in perinuclear invaginations and reduced virus growth.

Authors:  Daniel Schumacher; Caleb McKinney; Benedikt B Kaufer; Nikolaus Osterrieder
Journal:  Virology       Date:  2008-03-04       Impact factor: 3.616

9.  Marek's disease viral interleukin-8 promotes lymphoma formation through targeted recruitment of B cells and CD4+ CD25+ T cells.

Authors:  Annemarie T Engel; Ramesh K Selvaraj; Jeremy P Kamil; Nikolaus Osterrieder; Benedikt B Kaufer
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

10.  Herpesvirus telomeric repeats facilitate genomic integration into host telomeres and mobilization of viral DNA during reactivation.

Authors:  Benedikt B Kaufer; Keith W Jarosinski; Nikolaus Osterrieder
Journal:  J Exp Med       Date:  2011-03-07       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.